ClinicalTrials.gg

Program

Test Dentifrice

Its studies are mostly in Dental Plaque · Dentin Sensitivity · Dental Caries, led by HALEON.

Furthest: no phase, since Nov 21, 20235 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
HALEON50 open or runningno phasesince Nov 21, 2023Nov 21, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 21, 2023First study: no phase study in Dentin SensitivityFirst studyNCT06150573 · 160 enrolled · United States
  2. Apr 22, 2025No phase study in Dental CariesNCT06949072 · 47 enrolled · United States
  3. Nov 19, 2025No phase study in Dental PlaqueNCT07255040 · 284 enrolled · United States
  4. Dec 19, 2025No phase study in Dentin SensitivityNCT07317128 · 120 enrolled · China
  5. Jul 10, 2026No phase study in Dental PlaqueNCT07704905 · 110 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07704905Dental Plaque · United States–CompletedSep 30, 2026110
NCT07317128Dentin Sensitivity · China–CompletedJun 8, 2013120
NCT07255040Dental Plaque · United States–CompletedJul 30, 2026284
NCT06949072Dental Caries · United States–CompletedSep 11, 202547
NCT06150573Dentin Sensitivity · United States–CompletedJul 18, 2024160

How it is read

Names in the registry

  • “Test Dentifrice”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.